Sulfaperin

From WikiMD's WELLNESSPEDIA

Chemical structure of Sulfaperin

Sulfaperin is a sulfonamide antibiotic that was historically used to treat bacterial infections. It belongs to the class of drugs known as sulfa drugs, which are synthetic antimicrobial agents containing the sulfonamide group. Sulfaperin works by inhibiting the growth and multiplication of bacteria, making it effective against a wide range of bacterial infections.

Mechanism of Action[edit]

Sulfaperin, like other sulfonamides, acts as a competitive inhibitor of the bacterial enzyme dihydropteroate synthase. This enzyme is crucial in the bacterial synthesis of folic acid, which is necessary for the production of nucleic acids and ultimately for bacterial growth and replication. By inhibiting this enzyme, sulfaperin effectively starves the bacteria of folic acid, leading to their death.

Clinical Uses[edit]

Sulfaperin was used to treat various infections caused by Gram-positive and Gram-negative bacteria. It was particularly effective in treating urinary tract infections, respiratory tract infections, and certain types of gastrointestinal infections. However, with the development of newer antibiotics with fewer side effects and broader spectra of activity, the use of sulfaperin has declined.

Side Effects[edit]

The use of sulfaperin, like other sulfonamides, can lead to several side effects. Common side effects include allergic reactions, such as rash and fever. More severe reactions can include Stevens-Johnson syndrome, toxic epidermal necrolysis, and hemolytic anemia. Patients with a known allergy to sulfonamides should avoid using sulfaperin.

Resistance[edit]

Bacterial resistance to sulfonamides, including sulfaperin, has been a growing concern. Resistance mechanisms include the production of an altered dihydropteroate synthase enzyme that has a reduced affinity for the drug, increased production of para-aminobenzoic acid (PABA), and the acquisition of resistance genes through horizontal gene transfer.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.